Toshio Fujino

KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In Vitro Experiments

T. Koga, Kenichi Suda, Toshio Fujino et al. · Journal of Thoracic Oncology · 2021 · 251 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro

Toshio Fujino, Yoshihisa Kobayashi, Kenichi Suda et al. · Journal of Thoracic Oncology · 2019 · 175 citations · Full text

Medicine, Oncology, Pharmacology +14

Tumor antigen of human cervical squamous cell carcinoma.Correlation of circulating levels with disease progress

Hiroshi Kato, F Miyauchi, Hitoshi Morioka et al. · Cancer · 1979 · 110 citations

Medicine, Immunology, Oncology +13

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer

Sun Min Lim, Toshio Fujino, Chulwon Kim et al. · Clinical Cancer Research · 2023 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15

Activity of a novel HER2 inhibitor, poziotinib, for HER2 exon 20 mutations in lung cancer and mechanism of acquired resistance: An in vitro study

T. Koga, Yoshihisa Kobayashi, Kenji Tomizawa et al. · Lung Cancer · 2018 · 68 citations · Full text

Medicine, Oncology, Pharmacology +16